Loading…

Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis

It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than us...

Full description

Saved in:
Bibliographic Details
Published in:American journal of medical genetics. Part B, Neuropsychiatric genetics Neuropsychiatric genetics, 2005-07, Vol.136B (1), p.87-91
Main Authors: Chen, Chih-Ken, Lin, Shih-Ku, Sham, Pak C., Ball, David, Loh, El-Wui, Murray, Robin M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3
cites cdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3
container_end_page 91
container_issue 1
container_start_page 87
container_title American journal of medical genetics. Part B, Neuropsychiatric genetics
container_volume 136B
creator Chen, Chih-Ken
Lin, Shih-Ku
Sham, Pak C.
Ball, David
Loh, El-Wui
Murray, Robin M.
description It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P 
doi_str_mv 10.1002/ajmg.b.30187
format article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ajmg_b_30187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_Q02G1QTF_L</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</originalsourceid><addsrcrecordid>eNp9kE1PwkAURSdGI4juXJv5ARbno9PWJSFSNaAhwehuMtO-0oGWNjNF5N8LFHXn6t3FuSd5F6FrSvqUEHanFuW8r_uc0Cg8QV0qBPP8SHyc_mafdtCFcwtCOBFheI46VET3jArSRcWkstqk2Bq3xFllce22SW5UY02CU-Mqm4LFqqxWc9zkgC0UqjGf4HCV4RKaXJV1Do0qzQrw2oF1eGOaHKtVegjVummVlTPuEp1lqnBwdbw99DZ6mA0fvfFr_DQcjL3EJyz0OPc1qEAoXwGwxAedUSA0CBTjYQQJ14KoRAcJzXaPck64HwWpSinzw4Bp4D1023oTWzlnIZO1NaWyW0mJ3I8m96NJLQ-j7fCbFq_XuoT0Dz6utAN4C2xMAdt_ZXLwPIl_tF7bMq6Br9-WsksZhDwU8v0lllPCYjqdjeSYfwNnRoqF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Chen, Chih-Ken ; Lin, Shih-Ku ; Sham, Pak C. ; Ball, David ; Loh, El-Wui ; Murray, Robin M.</creator><creatorcontrib>Chen, Chih-Ken ; Lin, Shih-Ku ; Sham, Pak C. ; Ball, David ; Loh, El-Wui ; Murray, Robin M.</creatorcontrib><description>It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P &lt; 0.001) than the relatives of those probands who never became psychotic. Furthermore, the MR for schizophrenia in the relatives of the subjects with a prolonged MAMP psychosis (MIP‐P) was higher than in the relatives of those users with a brief MAMP psychosis (MIP‐B) (OR = 2.8, 95% CI: 1.0–8.0, P = 0.042). The greater his or her familial loading for schizophrenia, the more likely a MAMP user is to develop psychosis, and the longer that psychosis is likely to last. © 2005 Wiley‐Liss, Inc.</description><identifier>ISSN: 1552-4841</identifier><identifier>EISSN: 1552-485X</identifier><identifier>DOI: 10.1002/ajmg.b.30187</identifier><identifier>PMID: 15892150</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; amphetamine ; Amphetamine-Related Disorders - epidemiology ; Amphetamine-Related Disorders - genetics ; Comorbidity ; familial risk ; Family ; Female ; genetic disposition ; Humans ; Interviews as Topic ; Male ; Mental Disorders - genetics ; Methamphetamine - poisoning ; Prevalence ; psychosis ; Psychotic Disorders - epidemiology ; Psychotic Disorders - etiology ; Risk Factors ; schizophrenia ; Schizophrenia - epidemiology ; Schizophrenia - genetics ; substance abuse</subject><ispartof>American journal of medical genetics. Part B, Neuropsychiatric genetics, 2005-07, Vol.136B (1), p.87-91</ispartof><rights>Copyright © 2005 Wiley‐Liss, Inc.</rights><rights>Copyright 2005 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</citedby><cites>FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15892150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Chih-Ken</creatorcontrib><creatorcontrib>Lin, Shih-Ku</creatorcontrib><creatorcontrib>Sham, Pak C.</creatorcontrib><creatorcontrib>Ball, David</creatorcontrib><creatorcontrib>Loh, El-Wui</creatorcontrib><creatorcontrib>Murray, Robin M.</creatorcontrib><title>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</title><title>American journal of medical genetics. Part B, Neuropsychiatric genetics</title><addtitle>Am. J. Med. Genet</addtitle><description>It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P &lt; 0.001) than the relatives of those probands who never became psychotic. Furthermore, the MR for schizophrenia in the relatives of the subjects with a prolonged MAMP psychosis (MIP‐P) was higher than in the relatives of those users with a brief MAMP psychosis (MIP‐B) (OR = 2.8, 95% CI: 1.0–8.0, P = 0.042). The greater his or her familial loading for schizophrenia, the more likely a MAMP user is to develop psychosis, and the longer that psychosis is likely to last. © 2005 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>amphetamine</subject><subject>Amphetamine-Related Disorders - epidemiology</subject><subject>Amphetamine-Related Disorders - genetics</subject><subject>Comorbidity</subject><subject>familial risk</subject><subject>Family</subject><subject>Female</subject><subject>genetic disposition</subject><subject>Humans</subject><subject>Interviews as Topic</subject><subject>Male</subject><subject>Mental Disorders - genetics</subject><subject>Methamphetamine - poisoning</subject><subject>Prevalence</subject><subject>psychosis</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Psychotic Disorders - etiology</subject><subject>Risk Factors</subject><subject>schizophrenia</subject><subject>Schizophrenia - epidemiology</subject><subject>Schizophrenia - genetics</subject><subject>substance abuse</subject><issn>1552-4841</issn><issn>1552-485X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PwkAURSdGI4juXJv5ARbno9PWJSFSNaAhwehuMtO-0oGWNjNF5N8LFHXn6t3FuSd5F6FrSvqUEHanFuW8r_uc0Cg8QV0qBPP8SHyc_mafdtCFcwtCOBFheI46VET3jArSRcWkstqk2Bq3xFllce22SW5UY02CU-Mqm4LFqqxWc9zkgC0UqjGf4HCV4RKaXJV1Do0qzQrw2oF1eGOaHKtVegjVummVlTPuEp1lqnBwdbw99DZ6mA0fvfFr_DQcjL3EJyz0OPc1qEAoXwGwxAedUSA0CBTjYQQJ14KoRAcJzXaPck64HwWpSinzw4Bp4D1023oTWzlnIZO1NaWyW0mJ3I8m96NJLQ-j7fCbFq_XuoT0Dz6utAN4C2xMAdt_ZXLwPIl_tF7bMq6Br9-WsksZhDwU8v0lllPCYjqdjeSYfwNnRoqF</recordid><startdate>20050705</startdate><enddate>20050705</enddate><creator>Chen, Chih-Ken</creator><creator>Lin, Shih-Ku</creator><creator>Sham, Pak C.</creator><creator>Ball, David</creator><creator>Loh, El-Wui</creator><creator>Murray, Robin M.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20050705</creationdate><title>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</title><author>Chen, Chih-Ken ; Lin, Shih-Ku ; Sham, Pak C. ; Ball, David ; Loh, El-Wui ; Murray, Robin M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>amphetamine</topic><topic>Amphetamine-Related Disorders - epidemiology</topic><topic>Amphetamine-Related Disorders - genetics</topic><topic>Comorbidity</topic><topic>familial risk</topic><topic>Family</topic><topic>Female</topic><topic>genetic disposition</topic><topic>Humans</topic><topic>Interviews as Topic</topic><topic>Male</topic><topic>Mental Disorders - genetics</topic><topic>Methamphetamine - poisoning</topic><topic>Prevalence</topic><topic>psychosis</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Psychotic Disorders - etiology</topic><topic>Risk Factors</topic><topic>schizophrenia</topic><topic>Schizophrenia - epidemiology</topic><topic>Schizophrenia - genetics</topic><topic>substance abuse</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Chih-Ken</creatorcontrib><creatorcontrib>Lin, Shih-Ku</creatorcontrib><creatorcontrib>Sham, Pak C.</creatorcontrib><creatorcontrib>Ball, David</creatorcontrib><creatorcontrib>Loh, El-Wui</creatorcontrib><creatorcontrib>Murray, Robin M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of medical genetics. Part B, Neuropsychiatric genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Chih-Ken</au><au>Lin, Shih-Ku</au><au>Sham, Pak C.</au><au>Ball, David</au><au>Loh, El-Wui</au><au>Murray, Robin M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis</atitle><jtitle>American journal of medical genetics. Part B, Neuropsychiatric genetics</jtitle><addtitle>Am. J. Med. Genet</addtitle><date>2005-07-05</date><risdate>2005</risdate><volume>136B</volume><issue>1</issue><spage>87</spage><epage>91</epage><pages>87-91</pages><issn>1552-4841</issn><eissn>1552-485X</eissn><abstract>It is not clear why some methamphetamine (MAMP) abusers develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We tested the hypotheses that those users who develop MAMP‐induced psychosis (MIP) have greater familial loading for psychotic disorders than users with no psychosis. Four hundred forty‐five MAMP users were recruited from a psychiatric hospital and a detention center in Taipei, and were assessed with the Diagnostic Interview for genetic studies (DIGS‐C) and the Family Interview for genetic study (FIGS‐C). Morbid risk (MR) for psychiatric disorders in first‐degree relatives was compared between those MAMP users with a lifetime diagnosis of MAMP psychosis and those without. The relatives of MAMP users with a lifetime diagnosis of MAMP psychosis had a significantly higher MR for schizophrenia (OR = 5.4, 95% CI: 2.0–14.7, P &lt; 0.001) than the relatives of those probands who never became psychotic. Furthermore, the MR for schizophrenia in the relatives of the subjects with a prolonged MAMP psychosis (MIP‐P) was higher than in the relatives of those users with a brief MAMP psychosis (MIP‐B) (OR = 2.8, 95% CI: 1.0–8.0, P = 0.042). The greater his or her familial loading for schizophrenia, the more likely a MAMP user is to develop psychosis, and the longer that psychosis is likely to last. © 2005 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15892150</pmid><doi>10.1002/ajmg.b.30187</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1552-4841
ispartof American journal of medical genetics. Part B, Neuropsychiatric genetics, 2005-07, Vol.136B (1), p.87-91
issn 1552-4841
1552-485X
language eng
recordid cdi_crossref_primary_10_1002_ajmg_b_30187
source Wiley-Blackwell Read & Publish Collection
subjects Adult
amphetamine
Amphetamine-Related Disorders - epidemiology
Amphetamine-Related Disorders - genetics
Comorbidity
familial risk
Family
Female
genetic disposition
Humans
Interviews as Topic
Male
Mental Disorders - genetics
Methamphetamine - poisoning
Prevalence
psychosis
Psychotic Disorders - epidemiology
Psychotic Disorders - etiology
Risk Factors
schizophrenia
Schizophrenia - epidemiology
Schizophrenia - genetics
substance abuse
title Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A58%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Morbid%20risk%20for%20psychiatric%20disorder%20among%20the%20relatives%20of%20methamphetamine%20users%20with%20and%20without%20psychosis&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20B,%20Neuropsychiatric%20genetics&rft.au=Chen,%20Chih-Ken&rft.date=2005-07-05&rft.volume=136B&rft.issue=1&rft.spage=87&rft.epage=91&rft.pages=87-91&rft.issn=1552-4841&rft.eissn=1552-485X&rft_id=info:doi/10.1002/ajmg.b.30187&rft_dat=%3Cistex_cross%3Eark_67375_WNG_Q02G1QTF_L%3C/istex_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4027-334bea65a4aee2c4ebf1e0166a2378ec3b50acb6c1f4853303486dad124762be3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15892150&rfr_iscdi=true